Roche tops cancer reputation rankings as AstraZeneca climbs back
AstraZeneca has impressed oncology patient groups, rising to second place on PatientView’s corporate reputation ranking on the back…
Roche H1 Sales Decline on Currency Headwinds, Key Drugs Keep Momentum
Swiss pharma giant Roche Holding AG RHHBY reported sales of CHF 30.4 billion ($38.6 billion) in the first…
Roche H1 Sales Decline on Currency Headwinds, Key Drugs Keep Momentum
Swiss pharma giant Roche Holding AG RHHBY reported sales of CHF 30.4 billion ($38.6 billion) in the first…
Roche pens $490m Astex breast cancer license deal
Roche has taken fresh steps to uphold its breast cancer legacy defined by Herceptin (trastuzumab) and Perjeta (pertuzumab),…
Roche enters $2 billion cancer drug agreement with Nurix Therapeutics
ZURICH, June 8 (Reuters) – Swiss pharmaceutical giant Roche has entered an exclusive licensing and collaboration agreement with…
Roche’s 2024 Sales and Earnings Beat, Key Drugs Perform Well
Swiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for 2025.…
Roche bets $700M upfront on Nurix’s late-phase BTK degrader
Roche is paying Nurix Therapeutics $700 million upfront for rights to bexobrutideg, securing a stake in a BTK degrader…
NRIX Stock Surges Nearly 70% Premarket Today – Roche And Nurix’s Blood Cancer Drug Collaboration Can Tap A $41B Market
Roche will pay Nurix $700 million up front, with up to $1.6 billion in future payouts if certain…
Roche enters $2 billion cancer drug agreement with Nurix Therapeutics
Mon, June 8, 2026 at 7:50 AM UTC FILE PHOTO: The logo of Swiss drugmaker Roche is seen…
FDA Approval Gives BeOne Medicines a New Challenger to AbbVie, Roche Cancer Drug
Several drugs are available for mantle cell lymphoma, but relapse is common in this rare blood cancer. When…
RHHBY’s Q1 Results Hit by Currency Headwinds, Sales Up 6% at CER
Swiss pharma giant Roche Holding AG’s RHHBY first-quarter 2026 results were affected by currency headwinds. Sales totaled $18.8…
Managing Quality of Life with CML
Understanding chronic myeloid leukemia Chronic myeloid leukaemia (CML) is a type of cancer that develops in the blood-forming…